Sonoma Pharmaceuticals, Inc.
(NASDAQ : SNOA)

( )
SNOA PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
3.41%19.121.8%$142.91m
ICPTIntercept Pharmaceuticals, Inc.
-2.54%88.9118.6%$96.35m
SAGESAGE Therapeutics, Inc.
-0.30%163.978.8%$79.34m
JAZZJazz Pharmaceuticals Plc
-0.69%128.532.3%$69.92m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.88%162.456.3%$58.85m
PRGOPerrigo Co. Plc
1.91%50.146.8%$53.83m
ZGNXZogenix, Inc.
0.47%38.249.9%$47.81m
UTHRUnited Therapeutics Corporation
-1.41%102.0414.3%$44.82m
CTLTCatalent Inc
0.38%44.622.4%$39.80m
PTLAPortola Pharmaceuticals, Inc.
0.64%35.997.6%$33.80m
HZNPHorizon Pharma plc
0.64%25.306.7%$33.60m
ICLRICON Plc
1.67%136.924.1%$31.71m
ZYNEZynerba Pharmaceuticals Inc
3.20%10.338.3%$31.11m
MYOKMyoKardia, Inc.
2.85%49.052.1%$25.90m
MDCOMedicines Company
1.15%29.8021.8%$25.70m

Company Profile

Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. It offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.